News & Articles

Participation will help advance liquid biopsy adoption by collaborating among key industry stakeholders

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations

Our expert webinar series aims to help you get the most from your drug discovery research

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

A rare lung disease drug is being trialed to help fight COVID-19

Advance your COVID-19 research with positive and negative SARS-CoV-2 samples

The study is expected to begin enrolling in June with a target of approximately 450 patients globally

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research

Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers' specific analytical requirements

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events